Contraceptive Technology Update
RSSArticles
-
Single-size Caya diaphragm is available by prescription in U.S.
The Caya single-size diaphragm, the first new cervical barrier method to enter the market in more than 10 years, is available by prescription from U.S. healthcare providers.
-
Counseling on LARC methods cuts unintended pregnancy rates
Training clinicians to inform women that different birth control methods have very different levels of effectiveness proved key in cutting the number of unintended pregnancies among young women seeking family planning services, data suggests from a new national study from the Bixby Center for Global and Reproductive Health at the University of California, San Francisco.
-
Are women getting screened for osteoporosis? Just-released research suggests answer is ‘no’
Too few women at high risk for osteoporosis are being tested for the condition, while too many women at low risk are being screened, results of a California-based study suggest.
-
At least 20 insurers aren’t offering Affordable Care Act’s breastfeeding benefits
Breastfeeding rates continue to rise. In 2011, 79% of U.S. newborn infants started to breastfeed, according to the Centers for Disease Control and Prevention.
-
Research indicates text messages can aid adolescent adherence to contraceptive use
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections aids in improving timing and adherence to contraception, research indicates.
-
Time to change Medicaid sterilization wait period
U.S. health policy requires Medicaid beneficiaries to wait 30 days before tubal sterilization. In a journal analysis, national experts argue that this practice violates healthcare justice, as elective tubal sterilization is readily available to women with a private source of payment.
-
New research indicates promise of nine-valent human papillomavirus vaccine
The recently approved nine-valent human papillomavirus vaccine potentially can prevent 80% of cervical cancers in the United States if given to all 11- or 12-year-old children before they are exposed to the virus, results of a new seven-center study suggest.
-
Research adds more insight into newer OCs and risk of VTE
Results from two United Kingdom population-based, case-control nested studies using two large primary care databases indicate risks of venous thromboembolism associated with combined oral contraceptives were, with the exception of norgestimate, higher for newer drug preparations than for second-generation drugs.
-
Drug-related HIV outbreak spurs CDC to issue nationwide alert
The CDC has issued a national health advisory in light of its investigation with the Indiana State Department of Health of a large outbreak of recent HIV infections among persons in Indiana who inject drugs.
-
CDC clinical advisory: Be on the lookout for ocular syphilis cases in the United States
Since December 2014, 24 cases of ocular syphilis have been reported from California and Washington, with several other states reporting potential cases, according to the CDC.